Cargando…
Evaluation of respiratory complications in a cohort of preterm infants who did not receive palivizumab monoclonal antibodies
OBJECTIVES: to analyze the occurrence of respiratory complications over the first year of life in preterm infants who did not receive palivizumab monoclonal antibodies. METHODS: analytical retrospective cohort study with preterm infants born between 2012 and 2016 in Uberlândia, state of Minas Gerais...
Autores principales: | Bonati, Poliana Castro de Resende, Furtado, Maria Cândida de Carvalho, de Mello, Débora Falleiros, Wolkers, Paula Carolina Bejo, Faria, Gabriel de Oliveira, Ferreira, Daniela Marques de Lima Mota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Enfermagem
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728898/ https://www.ncbi.nlm.nih.gov/pubmed/36197428 http://dx.doi.org/10.1590/0034-7167-2021-0362 |
Ejemplares similares
-
Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab
por: Manini, Mariana Bueno, et al.
Publicado: (2021) -
Presence and extent of the primary health care attributes among children
hospitalized for pneumonia
por: Pina, Juliana Coelho, et al.
Publicado: (2015) -
Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
por: Boivin, Guy, et al.
Publicado: (2008) -
Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab
por: Mulot, Gwenaelle, et al.
Publicado: (2022) -
Using geo-spatial analysis for assessing the risk of hospital admissions due to community-acquired pneumonia in under-5 children and its association with socially vulnerable areas (Brazil)
por: Pina, Juliana Coelho, et al.
Publicado: (2020)